Almost half of adults and children with neurofibromatosis type 1 (NF1) responded to the investigational MEK inhibitor ...

Montreal’s two children’s hospitals are asking parents to avoid pediatric emergency rooms unless their child needs immediate ...

This spike has raised concerns among health professionals.

Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.

Young children are particularly vulnerable to the disease, which killed an estimated 107,500 people in 2023, most of whom ...

Walking pneumonia cases are on the rise in Lancaster County and across the region, and an expert says more very young ...

Montreal pediatric hospitals are surging over capacity and asking parents to avoid the emergency department unless their ...

Healthcare centers across D.C., Maryland and Northern Virginia recorded a more than 300% increase in cases since this time ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

The two biggest children’s hospitals in Montreal - the CHU Sainte-Justine and Montreal Children's Hospital - are asking ...

The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransferase 2A gene ( ...